Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Filings indexed 461 across all filing types
Latest filing 2021-04-22 Report Publication Anno…
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and details of an Investor Relations (IR) event (기업설명회). It provides the date, location, purpose, and agenda for the meeting. Since it is an announcement of an upcoming presentation rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement of an event, it is classified as a Regulatory Filing (RNS).
2021-04-22 Korean
기타경영사항(특허권취득)(자율공시)(신규 EGFRvlll 항체 및 이를 포함하는 조성물)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (PharmAbcine) regarding the acquisition of a patent ('기타 경영사항(특허권 취득)'). It provides details about the patent, its application, and the legal status. Since it does not fit into specific categories like financial reports, board changes, or dividends, and is a standard regulatory disclosure filed with the exchange, it falls under the general regulatory filing category.
2021-04-21 Korean
[기재정정]기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (PharmAbcine) regarding a patent acquisition. It is a 'voluntary disclosure' (자율공시) concerning a correction to a previously filed patent acquisition notice. Since it does not fit into specific categories like financial reports, board changes, or shareholder meetings, and is a standard regulatory disclosure of corporate activity, it falls under the RNS (Regulatory Filings) category.
2021-04-21 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (Annual General Meeting) for the company 'PharmAbcine'. It details the approval of financial statements, dividend decisions, and board/management appointments. This falls under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the outcome of shareholder votes at a general meeting.
2021-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company PharmAbcine. It contains the auditor's opinion, financial statements (consolidated and separate), and details regarding financial performance and audit results. While it contains financial data, it is specifically the regulatory filing of the audit report itself, which falls under the 'Audit Report / Information' category. FY 2020
2021-03-17 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2020 (Jan 1, 2020 to Dec 31, 2020) for PharmAbcine Inc. It contains detailed financial information, management discussion, capital structure, and corporate governance details. In the context of Korean regulatory filings (DART), a 'Business Report' (사업보고서) is the equivalent of an Annual Report (10-K). FY 2020
2021-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.